New Edge Advisors, LLC Lantern Pharma Inc. Transaction History
New Edge Advisors, LLC
- $13.5 Billion
- Q2 2024
A detailed history of New Edge Advisors, LLC transactions in Lantern Pharma Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 157,124 shares of LTRN stock, worth $507,510. This represents 0.01% of its overall portfolio holdings.
Number of Shares
157,124
Previous 160,532
2.12%
Holding current value
$507,510
Previous $1.41 Million
48.09%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding LTRN
# of Institutions
40Shares Held
1.27MCall Options Held
42.8KPut Options Held
5.6K-
Vanguard Group Inc Valley Forge, PA364KShares$1.17 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA86.3KShares$278,9000.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny81.8KShares$264,2140.0% of portfolio
-
Cm Management, LLC80KShares$258,4000.35% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA59.8KShares$193,0210.0% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $35M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...